Role of vascular endothelial growth factor in angiodysplasia: An interventional study with thalidomide

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 6, 2012, Pages 1094-1101

  Tan, Honghong ^a   Chen, Huimin ^a   Xu, Chunhong ^a   Ge, Zhizheng ^a   Gao, Yunjie ^a   Fang, Jingyuan ^a   Liu, Wenzhong ^a   Xiao, Shudong ^a  

^a School of Medicine   (China)

Author keywords

Angiodysplasia; Basic fibroblast growth factor; Hypoxia inducible factor 1; Thalidomide; Vascular endothelial growth factor

Indexed keywords

FIBROBLAST GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; THALIDOMIDE; VASCULOTROPIN;

ADULT; AGED; ANGIODYSPLASIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

EID: 84861471819     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06967.x     Document Type: Article

References (21)

1. Regula J, Wronska E, Pachlewski J. Vascular lesions of the gastrointestinal tract. Best Pract. Res. Clin. Gastroenterol. 2008; 22: 313-28.
2. Hodgson H. Hormonal therapy for gastrointestinal angiodysplasia. Lancet 2002; 359: 1630-1.
3. Ell C, Remke S, May A, Helou L, Henrich R, Mayer G. The first prospective controlled trial comparing wireless capsule endoscopy with push enteroscopy in chronic gastrointestinal bleeding. Endoscopy 2002; 34: 685-9.
4. Macdonald J, Porter V, Scott NW, McNamara D. Small bowel lymphangiectasia and angiodysplasia: a positive association; novel clinical marker or shared pathophysiology? J. Clin. Gastroenterol. 2010; 44: 610-4.
5. Junquera F, Saperas E, de Torres I, Vidal MT, Malagelada JR. Increased expression of angiogenic factors in human colonic angiodysplasia. Am. J. Gastroenterol. 1999; 94: 1070-6.
6. Klagsbrun M, D'Amore PA. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev. 1996; 7: 259-7.
7. Huang YF, Yang CH, Huang CC, Tai MH, Hsu KS. Pharmacological and genetic accumulation of hypoxia-inducible factor-1alpha enhances excitatory synaptic transmission in hippocampal neurons through the production of vascular endothelial growth factor. J. Neurosci. 2010; 30: 6080-93.
8. Seghezzi G, Patel S, Ren CJ etal. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J. Cell Biol. 1998; 141: 1659-73.
9. Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671-4.
10. Jiang BH, Rue E, Wang GL, Roe R, Semenza GL. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 1996; 271: 17771-8.
11. Guillemin K, Krasnow MA. The hypoxic response: huffing and HIFing. Cell 1997; 89: 9-12.
12. Schweigerer L, Neufeld G, Friedman J, Abraham JA, Fiddes JC, Gospodarowicz D. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 1987; 325: 257-9.
13. Shurafa M, Kamboj G. Thalidomide for the treatment of bleeding angiodysplasias. Am. J. Gastroenterol. 2003; 98: 221-2.
14. Bauditz J, Schachschal G, Wedel S, Lochs H. Thalidomide for treatment of severe intestinal bleeding. Gut 2004; 53: 609-12.
15. Plummer JM, Gibson TN, Mitchell DI, Herbert J, Henry T. Emergency subtotal colectomy for lower gastrointestinal haemorrhage: over-utilised or under-estimated? Int. J. Clin. Pract. 2009; 63: 865-8.
16. Chae KS, Kang MJ, Lee JH etal. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions. Oncogene 2011; 30: 1213-28.
17. Forsythe JA, Jiang BH, Iyer NV etal. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 1996; 16: 4604-13.
18. Kimura H, Weisz A, Kurashima Y etal. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 2000; 95: 189-97.
19. Lebrin F, Srun S, Raymond K etal. Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat. Med. 2010; 16: 420-8.
20. Ge ZZ, Chen HM, Gao YJ etal. Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation. Gastroenterology 2011; 141: 1629-37.
21. Tabata C, Tabata R, Kadokawa Y etal. Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice. J. Immunol. 2007; 179: 708-14.